State of Wyoming’s Atara Biotherapeutics ATRA Stock Holding History

State of Wyoming’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14	Closed	-$3K	–	1538
2022 Q2	$3K	Sell	14 -135	-91%	-$22K	﹤0.01%	1754
2022 Q1	$35K	Buy	149 +28	+23%	+$8.92K	0.02%	1235
2021 Q4	$48K	Buy	121 +3	+3%	+$1.26K	0.02%	1123
2021 Q3	$53K	Sell	118 -91	-44%	-$32.6K	0.03%	740
2021 Q2	$81K	Buy	209 +129	+161%	+$46K	0.05%	546
2021 Q1	$29K	Buy	+80	New	+$35.4K	0.05%	278

Other funds holding ATRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wyoming's ATRA Position: Q3 2022 in Review

State of Wyoming sold out of Atara Biotherapeutics (ATRA) in Q3 2022, closing a stake of 14 shares — an estimated $3K sold.

State of Wyoming first reported a position in ATRA in Q1 2021 and held it in 6 quarters. The position peaked at $81K in Q2 2021. 154 funds tracked by Wall St. Rank hold ATRA as of Q3 2022.

State of Wyoming reported no remaining Atara Biotherapeutics position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 14 Atara Biotherapeutics shares in Q3 2022, an estimated $3K.
State of Wyoming first reported a position in Atara Biotherapeutics in Q1 2021 and held it in 6 quarters.
State of Wyoming's Atara Biotherapeutics position peaked at $81K in Q2 2021.
154 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.